kth.sePublications
Change search
Link to record
Permanent link

Direct link
Publications (10 of 71) Show all publications
Royer, P., Björnson, E., Adiels, M., Alvez, M. B., Fagerberg, L., Bäckhed, F., . . . Bergström, G. (2024). Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention. American Heart Journal, 271, 55-67
Open this publication in new window or tab >>Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention
Show others...
2024 (English)In: American Heart Journal, ISSN 0002-8703, E-ISSN 1097-6744, Vol. 271, p. 55-67Article in journal (Refereed) Published
Abstract [en]

Background and aims: Recent developments in high-throughput proteomic technologies enable the discovery of novel biomarkers of coronary atherosclerosis. The aims of this study were to test if plasma protein subsets could detect coronary artery calcifications (CAC) in asymptomatic individuals and if they add predictive value beyond traditional risk factors. Methods: Using proximity extension assays, 1,342 plasma proteins were measured in 1,827 individuals from the Impaired Glucose Tolerance and Microbiota (IGTM) study and 883 individuals from the Swedish Cardiopulmonary BioImage Study (SCAPIS) aged 50-64 years without history of ischaemic heart disease and with CAC assessed by computed tomography. After data-driven feature selection, extreme gradient boosting machine learning models were trained on the IGTM cohort to predict the presence of CAC using combinations of proteins and traditional risk factors. The trained models were validated in SCAPIS. Results: The best plasma protein subset (44 proteins) predicted CAC with an area under the curve (AUC) of 0.691 in the validation cohort. However, this was not better than prediction by traditional risk factors alone (AUC = 0.710, P = .17). Adding proteins to traditional risk factors did not improve the predictions (AUC = 0.705, P = .6). Most of these 44 proteins were highly correlated with traditional risk factors. Conclusions: A plasma protein subset that could predict the presence of subclinical CAC was identified but it did not outperform nor improve a model based on traditional risk factors. Thus, support for this targeted proteomics platform to predict subclinical CAC beyond traditional risk factors was not found.

Place, publisher, year, edition, pages
Elsevier BV, 2024
National Category
Cardiology and Cardiovascular Disease
Identifiers
urn:nbn:se:kth:diva-344590 (URN)10.1016/j.ahj.2024.01.011 (DOI)001236907300001 ()38325523 (PubMedID)2-s2.0-85187378893 (Scopus ID)
Note

QC 20240327

Available from: 2024-03-20 Created: 2024-03-20 Last updated: 2025-02-10Bibliographically approved
Kotol, D., Woessmann, J., Hober, A., Alvez, M. B., Tran Minh, K. H., Pontén, F., . . . Edfors, F. (2023). Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma. Cancers, 15(19), Article ID 4764.
Open this publication in new window or tab >>Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma
Show others...
2023 (English)In: Cancers, ISSN 2072-6694, Vol. 15, no 19, article id 4764Article in journal (Refereed) Published
Abstract [en]

Mass spectrometry based on data-independent acquisition (DIA) has developed into a powerful quantitative tool with a variety of implications, including precision medicine. Combined with stable isotope recombinant protein standards, this strategy provides confident protein identification and precise quantification on an absolute scale. Here, we describe a comprehensive targeted proteomics approach to profile a pan-cancer cohort consisting of 1800 blood plasma samples representing 15 different cancer types. We successfully performed an absolute quantification of 253 proteins in multiplex. The assay had low intra-assay variability with a coefficient of variation below 20% (CV = 17.2%) for a total of 1013 peptides quantified across almost two thousand injections. This study identified a potential biomarker panel of seven protein targets for the diagnosis of multiple myeloma patients using differential expression analysis and machine learning. The combination of markers, including the complement C1 complex, JCHAIN, and CD5L, resulted in a prediction model with an AUC of 0.96 for the identification of multiple myeloma patients across various cancer patients. All these proteins are known to interact with immunoglobulins.

Place, publisher, year, edition, pages
MDPI AG, 2023
Keywords
DIA, multiple myeloma, precision medicine, targeted proteomics
National Category
Cancer and Oncology Hematology
Identifiers
urn:nbn:se:kth:diva-338876 (URN)10.3390/cancers15194764 (DOI)001086709700001 ()37835457 (PubMedID)2-s2.0-85173822408 (Scopus ID)
Note

QC 20231115

Available from: 2023-10-31 Created: 2023-10-31 Last updated: 2023-12-07Bibliographically approved
Alvez, M. B., Edfors, F., von Feilitzen, K., Zwahlen, M., Mardinoglu, A., Edqvist, P. H., . . . Uhlén, M. (2023). Next generation pan-cancer blood proteome profiling using proximity extension assay. Nature Communications, 14(1), Article ID 4308.
Open this publication in new window or tab >>Next generation pan-cancer blood proteome profiling using proximity extension assay
Show others...
2023 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 14, no 1, article id 4308Article in journal (Refereed) Published
Abstract [en]

A comprehensive characterization of blood proteome profiles in cancer patients can contribute to a better understanding of the disease etiology, resulting in earlier diagnosis, risk stratification and better monitoring of the different cancer subtypes. Here, we describe the use of next generation protein profiling to explore the proteome signature in blood across patients representing many of the major cancer types. Plasma profiles of 1463 proteins from more than 1400 cancer patients are measured in minute amounts of blood collected at the time of diagnosis and before treatment. An open access Disease Blood Atlas resource allows the exploration of the individual protein profiles in blood collected from the individual cancer patients. We also present studies in which classification models based on machine learning have been used for the identification of a set of proteins associated with each of the analyzed cancers. The implication for cancer precision medicine of next generation plasma profiling is discussed.

Place, publisher, year, edition, pages
Springer Nature, 2023
National Category
Cancer and Oncology Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
urn:nbn:se:kth:diva-333884 (URN)10.1038/s41467-023-39765-y (DOI)001037322100032 ()37463882 (PubMedID)2-s2.0-85165345608 (Scopus ID)
Note

QC 20230815

Available from: 2023-08-15 Created: 2023-08-15 Last updated: 2023-12-07Bibliographically approved
Jin, H., Zhang, C., Zwahlen, M., von Feilitzen, K., Karlsson, M., Shi, M., . . . Mardinoglu, A. (2023). Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation. Nature Communications, 14(1), 5417
Open this publication in new window or tab >>Systematic transcriptional analysis of human cell lines for gene expression landscape and tumor representation
Show others...
2023 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 14, no 1, p. 5417-Article in journal (Refereed) Published
Abstract [en]

Cell lines are valuable resources as model for human biology and translational medicine. It is thus important to explore the concordance between the expression in various cell lines vis-à-vis human native and disease tissues. In this study, we investigate the expression of all human protein-coding genes in more than 1,000 human cell lines representing 27 cancer types by a genome-wide transcriptomics analysis. The cell line gene expression is compared with the corresponding profiles in various tissues, organs, single-cell types and cancers. Here, we present the expression for each cell line and give guidance for the most appropriate cell line for a given experimental study. In addition, we explore the cancer-related pathway and cytokine activity of the cell lines to aid human biology studies and drug development projects. All data are presented in an open access cell line section of the Human Protein Atlas to facilitate the exploration of all human protein-coding genes across these cell lines.

Place, publisher, year, edition, pages
Springer Nature, 2023
National Category
Cell and Molecular Biology Cancer and Oncology
Identifiers
urn:nbn:se:kth:diva-336298 (URN)10.1038/s41467-023-41132-w (DOI)001063751200013 ()37669926 (PubMedID)2-s2.0-85169756281 (Scopus ID)
Note

QC 20230913

Available from: 2023-09-13 Created: 2023-09-13 Last updated: 2023-12-07Bibliographically approved
Zhong, W., Danielsson, H., Brusselaers, N., Wackernagel, D., Sjobom, U., Savman, K., . . . Hellström, A. (2023). The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern. Communications Medicine, 3(1), Article ID 107.
Open this publication in new window or tab >>The development of blood protein profiles in extremely preterm infants follows a stereotypic evolution pattern
Show others...
2023 (English)In: Communications Medicine, E-ISSN 2730-664X, Vol. 3, no 1, article id 107Article in journal (Refereed) Published
Abstract [en]

Background

Preterm birth is the leading cause of neonatal mortality and morbidity. Early diagnosis and interventions are critical to improving the clinical outcomes of extremely premature infants. Blood protein profiling during the first months of life in preterm infants can shed light on the role of early extrauterine development and provide an increased understanding of maturation after extremely preterm birth and the underlying mechanisms of prematurity-related disorders.

Methods

We have investigated the blood protein profiles during the first months of life in preterm infants on the role of early extrauterine development. The blood protein levels were analyzed using next generation blood profiling on 1335 serum samples, collected longitudinally at nine time points from birth to full-term from 182 extremely preterm infants.

Results

The protein analysis reveals evident predestined serum evolution patterns common for all included infants. The majority of the variations in blood protein expression are associated with the postnatal age of the preterm infants rather than any other factors. There is a uniform protein pattern on postnatal day 1 and after 30 weeks postmenstrual age (PMA), independent of gestational age (GA). However, during the first month of life, GA had a significant impact on protein variability.

Conclusions

The unified pattern of protein development for all included infants suggests an age-dependent stereotypic development of blood proteins after birth. This knowledge should be considered in neonatal settings and might alter the clinical approach within neonatology, where PMA is today the most dominant age variable.

Plain language summary

Being born too early can affect a baby's health. We looked at how babies born extremely preterm, meaning more than 12 weeks earlier than a full-term baby, develop. We looked at the proteins present in their blood from the day they were born until their original due date. Our study of 182 extremely preterm babies born at different points in the pregnancy (gestational ages) found that the proteins present in their blood changed in a similar way over time. This means that the age of a baby after birth, and not how early they were born, mostly affects the proteins in their blood. These findings help us understand how extremely preterm babies develop after birth, which could lead to improvements to their healthcare during the first few weeks of their life. Zhong, Danielsson et al. longitudinally profile the serum proteome in a cohort of extremely preterm infants. They identify a postnatal time-dependent stereotypic pattern of development in the blood proteome from premature birth to term-equivalent age.

Place, publisher, year, edition, pages
Springer Nature, 2023
National Category
Pediatrics Bioinformatics and Computational Biology
Identifiers
urn:nbn:se:kth:diva-334761 (URN)10.1038/s43856-023-00338-1 (DOI)001041575400001 ()37532738 (PubMedID)2-s2.0-85189872821 (Scopus ID)
Note

QC 20230824

Available from: 2023-08-24 Created: 2023-08-24 Last updated: 2025-05-27Bibliographically approved
Danielsson, H., Tebani, A., Zhong, W., Fagerberg, L., Brusselaers, N., Hård, A.-L., . . . Hellström, A. (2022). Blood protein profiles related to preterm birth and retinopathy of prematurity. Pediatric Research, 91(4), 937-946
Open this publication in new window or tab >>Blood protein profiles related to preterm birth and retinopathy of prematurity
Show others...
2022 (English)In: Pediatric Research, ISSN 0031-3998, E-ISSN 1530-0447, Vol. 91, no 4, p. 937-946Article in journal (Refereed) Published
Abstract [en]

Background: Nearly one in ten children is born preterm. The degree of immaturity is a determinant of the infant’s health. Extremely preterm infants have higher morbidity and mortality than term infants. One disease affecting extremely preterm infants is retinopathy of prematurity (ROP), a multifactorial neurovascular disease that can lead to retinal detachment and blindness. The advances in omics technology have opened up possibilities to study protein expressions thoroughly with clinical accuracy, here used to increase the understanding of protein expression in relation to immaturity and ROP.

Methods: Longitudinal serum protein profiles the first months after birth in 14 extremely preterm infants were integrated with perinatal and ROP data. In total, 448 unique protein targets were analyzed using Proximity Extension Assays.

Results: We found 20 serum proteins associated with gestational age and/or ROP functioning within mainly angiogenesis, hematopoiesis, bone regulation, immune function, and lipid metabolism. Infants with severe ROP had persistent lower levels of several identified proteins during the first postnatal months.

Conclusions: The study contributes to the understanding of the relationship between longitudinal serum protein levels and immaturity and abnormal retinal neurovascular development. This is essential for understanding pathophysiological mechanisms and to optimize diagnosis, treatment and prevention for ROP.

Impact: Longitudinal protein profiles of 14 extremely preterm infants were analyzed using a novel multiplex protein analysis platform combined with perinatal data. Proteins associated with gestational age at birth and the neurovascular disease ROP were identified. Among infants with ROP, longitudinal levels of the identified proteins remained largely unchanged during the first postnatal months. The main functions of the proteins identified were angiogenesis, hematopoiesis, immune function, bone regulation, lipid metabolism, and central nervous system development. The study contributes to the understanding of longitudinal serum protein patterns related to gestational age and their association with abnormal retinal neuro-vascular development. Longitudinal protein profiles of 14 extremely preterm infants were analyzed using a novel multiplex protein analysis platform combined with perinatal data.Proteins associated with gestational age at birth and the neurovascular disease ROP were identified.Among infants with ROP, longitudinal levels of the identified proteins remained largely unchanged during the first postnatal months.The main functions of the proteins identified were angiogenesis, hematopoiesis, immune function, bone regulation, lipid metabolism, and central nervous system development.The study contributes to the understanding of longitudinal serum protein patterns related to gestational age and their association with abnormal retinal neuro-vascular development.

Place, publisher, year, edition, pages
Springer Nature, 2022
Keywords
Pediatrics, Perinatology, and Child Health
National Category
Pediatrics Bioinformatics and Computational Biology
Identifiers
urn:nbn:se:kth:diva-303345 (URN)10.1038/s41390-021-01528-0 (DOI)000643173900001 ()33895781 (PubMedID)2-s2.0-85105242408 (Scopus ID)
Note

QC 20250430

Available from: 2021-10-12 Created: 2021-10-12 Last updated: 2025-04-30Bibliographically approved
Olsson, L. M., Boulund, F., Nilsson, S., Khan, M. T., Gummesson, A., Fagerberg, L., . . . Backhed, F. (2022). Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden. Cell Host and Microbe, 30(5), 726-739.e3
Open this publication in new window or tab >>Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden
Show others...
2022 (English)In: Cell Host and Microbe, ISSN 1931-3128, E-ISSN 1934-6069, Vol. 30, no 5, p. 726-739.e3Article in journal (Refereed) Published
Abstract [en]

Temporal dynamics of the gut microbiota potentially limit the identification of microbial features associated with health status. Here, we used whole-genome metagenomic and 16S rRNA gene sequencing to characterize the intra-and inter-individual variations of gut microbiota composition and functional potential of a disease-free Swedish population (n = 75) over one year. We found that 23% of the total compositional variance was explained by intra-individual variation. The degree of intra-individual compositional variability was negatively associated with the abundance of Faecalibacterium prausnitzii (a butyrate producer) and two Bifidobacterium species. By contrast, the abundance of facultative anaerobes and aerotolerant bacteria such as Escherichia coli and Lactobacillus acidophilus varied extensively, independent of compositional stability. The contribution of intra-individual variance to the total variance was greater for functional pathways than for microbial species. Thus, reliable quantification of microbial features requires repeated samples to address the issue of intra-individual variations of the gut microbiota.

Place, publisher, year, edition, pages
Elsevier BV, 2022
National Category
Microbiology
Identifiers
urn:nbn:se:kth:diva-318184 (URN)10.1016/j.chom.2022.03.002 (DOI)000832389500015 ()35349787 (PubMedID)2-s2.0-85129968123 (Scopus ID)
Note

QC 20220916

Available from: 2022-09-16 Created: 2022-09-16 Last updated: 2023-12-07Bibliographically approved
Wang, F., Karlsson, M., Fagerberg, L., Uhlén, M., Chen, D., Lin, L. & Luo, Y. (2022). Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level. Nature Communications, 13(1), Article ID 3620.
Open this publication in new window or tab >>Endothelial cell heterogeneity and microglia regulons revealed by a pig cell landscape at single-cell level
Show others...
2022 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 13, no 1, article id 3620Article in journal (Refereed) Published
Abstract [en]

Pigs are valuable large animal models for biomedical and genetic research, but insights into the tissue- and cell-type-specific transcriptome and heterogeneity remain limited. By leveraging single-cell RNA sequencing, we generate a multiple-organ single-cell transcriptomic map containing over 200,000 pig cells from 20 tissues/organs. We comprehensively characterize the heterogeneity of cells in tissues and identify 234 cell clusters, representing 58 major cell types. In-depth integrative analysis of endothelial cells reveals a high degree of heterogeneity. We identify several functionally distinct endothelial cell phenotypes, including an endothelial to mesenchymal transition subtype in adipose tissues. Intercellular communication analysis predicts tissue- and cell type-specific crosstalk between endothelial cells and other cell types through the VEGF, PDGF, TGF-beta, and BMP pathways. Regulon analysis of single-cell transcriptome of microglia in pig and 12 other species further identifies MEF2C as an evolutionally conserved regulon in the microglia. Our work describes the landscape of single-cell transcriptomes within diverse pig organs and identifies the heterogeneity of endothelial cells and evolutionally conserved regulon in microglia.

Place, publisher, year, edition, pages
Springer Nature, 2022
National Category
Cell Biology
Identifiers
urn:nbn:se:kth:diva-315532 (URN)10.1038/s41467-022-31388-z (DOI)000815536300017 ()35750885 (PubMedID)2-s2.0-85132918827 (Scopus ID)
Note

Correction in: Nature Communications, vol. 13, issue. 1. DOI: 10.1038/s41467-022-34498-w, WOS: 000885370100016, ScopusID: 2-s2.0-85141346712

QC 20220707

Available from: 2022-07-07 Created: 2022-07-07 Last updated: 2023-12-07Bibliographically approved
Karlsson, M., Sjostedt, E., Oksvold, P., Sivertsson, Å., Huang, J., Alvez, M. B., . . . Uhlén, M. (2022). Genome-wide annotation of protein-coding genes in pig. BMC Biology, 20(1), Article ID 25.
Open this publication in new window or tab >>Genome-wide annotation of protein-coding genes in pig
Show others...
2022 (English)In: BMC Biology, E-ISSN 1741-7007, Vol. 20, no 1, article id 25Article in journal (Refereed) Published
Abstract [en]

Background: There is a need for functional genome-wide annotation of the protein-coding genes to get a deeper understanding of mammalian biology. Here, a new annotation strategy is introduced based on dimensionality reduction and density-based clustering of whole-body co-expression patterns. This strategy has been used to explore the gene expression landscape in pig, and we present a whole-body map of all protein-coding genes in all major pig tissues and organs. Results: An open-access pig expression map (www.rnaatlas.org ) is presented based on the expression of 350 samples across 98 well-defined pig tissues divided into 44 tissue groups. A new UMAP-based classification scheme is introduced, in which all protein-coding genes are stratified into tissue expression clusters based on body-wide expression profiles. The distribution and tissue specificity of all 22,342 protein-coding pig genes are presented. Conclusions: Here, we present a new genome-wide annotation strategy based on dimensionality reduction and density-based clustering. A genome-wide resource of the transcriptome map across all major tissues and organs in pig is presented, and the data is available as an open-access resource (www.rnaatlas.org), including a comparison to the expression of human orthologs.

Place, publisher, year, edition, pages
Springer Nature, 2022
Keywords
Annotation, Protein coding genes, Genome wide, Transcriptome, Gene expression, Tissue expression profile
National Category
Biochemistry Molecular Biology Medical Biotechnology Bioinformatics and Computational Biology
Identifiers
urn:nbn:se:kth:diva-307759 (URN)10.1186/s12915-022-01229-y (DOI)000746863800002 ()35073880 (PubMedID)2-s2.0-85123754738 (Scopus ID)
Note

QC 20220209

Available from: 2022-02-09 Created: 2022-02-09 Last updated: 2025-02-20Bibliographically approved
Karlsson, M., Zhang, C., Mear, L., Zhong, W., Digre, A., Katona, B., . . . Lindskog, C. (2021). A single-cell type transcriptomics map of human tissues. Science Advances, 7(31), Article ID eabh2169.
Open this publication in new window or tab >>A single-cell type transcriptomics map of human tissues
Show others...
2021 (English)In: Science Advances, E-ISSN 2375-2548, Vol. 7, no 31, article id eabh2169Article in journal (Refereed) Published
Abstract [en]

Advances in molecular profiling have opened up the possibility to map the expression of genes in cells, tissues, and organs in the human body. Here, we combined single-cell transcriptomics analysis with spatial antibody-based protein profiling to create a high-resolution single-cell type map of human tissues. An open access atlas has been launched to allow researchers to explore the expression of human protein-coding genes in 192 individual cell type clusters. An expression specificity classification was performed to determine the number of genes elevated in each cell type, allowing comparisons with bulk transcriptomics data. The analysis highlights distinct expression clusters corresponding to cell types sharing similar functions, both within the same organs and between organs.

Place, publisher, year, edition, pages
American Association for the Advancement of Science (AAAS), 2021
National Category
Biochemistry Molecular Biology
Identifiers
urn:nbn:se:kth:diva-299689 (URN)10.1126/sciadv.abh2169 (DOI)000678723800005 ()34321199 (PubMedID)2-s2.0-85111485342 (Scopus ID)
Note

QC 20210817

Available from: 2021-08-17 Created: 2021-08-17 Last updated: 2025-02-20Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-0198-7137

Search in DiVA

Show all publications